Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kevin M, Wymer"'
Autor:
Kevin M, Wymer, Gopal, Narang, Austen, Slade, Vidit, Sharma, Viengneesee, Thao, Bijan J, Borah, Marcelino, Rivera, Scott, Cheney, Mitchell R, Humphreys
Publikováno v:
Urology. 171:96-102
To compare the cost-effectiveness of surgical interventions for BPH.Using a Markov model, a cost-utility analysis was performed comparing HoLEP, B-TURP, WVTT, and PUL for prostate size80cc (index patient 1) and HoLEP and SP for prostate size80cc (ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe802372eba5bdc059bbb55af91f4a1
https://doi.org/10.1016/j.urology.2022.09.026
https://doi.org/10.1016/j.urology.2022.09.026
Autor:
Daniel D. Joyce, Kevin M. Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Arman Walia, Brian A. Costello, Lance C. Pagliaro, Siamak Daneshmand, Bradley C. Leibovich, Stephen A. Boorjian
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::179be60ce00b56ee288ce704df58ca62
https://doi.org/10.1097/ju.0000000000003266.03
https://doi.org/10.1097/ju.0000000000003266.03
Autor:
Darlene Vargas Maldonado, Kevin M. Wymer, John B. Gebhart, Annetta M. Madsen, John A. Occhino, Emanuel C. Trabuco, Brian J. Linder
Publikováno v:
Female Pelvic Medicine & Reconstructive Surgery. 28:e103-e107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6381b36fd8df0fed094b1c977352b5ce
https://doi.org/10.1097/spv.0000000000001165
https://doi.org/10.1097/spv.0000000000001165
Autor:
Vidit, Sharma, Kevin M, Wymer, Daniel D, Joyce, James, Moriarty, Abhinav, Khanna, Bijan J, Borah, R Houston, Thompson, Brian A, Costello, Bradley C, Leibovich, Stephen A, Boorjian
Publikováno v:
The Journal of urology. 209(1)
The KEYNOTE-564 trial demonstrated that adjuvant pembrolizumab after nephrectomy for clear cell renal cell carcinoma decreased the risk of disease progression and potentially overall mortality as well. Herein, we used a Markov model to weigh the cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe75777a704ad0cccd2a65aa74ce003
https://pubmed.ncbi.nlm.nih.gov/36215681
https://pubmed.ncbi.nlm.nih.gov/36215681
Autor:
Daniel D. Joyce, Kevin M. Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Daniel M. Geynisman, Elizabeth R. Plimack, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian
Publikováno v:
CancerREFERENCES. 128(24)
The VESPER trial demonstrated improved progression-free (PFS) and (preliminarily) overall survival (OS) with six cycles of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVACx6) versus four cycles of gemcitabine and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56782625f23520a822d9ade69d4159b8
https://pubmed.ncbi.nlm.nih.gov/36251574
https://pubmed.ncbi.nlm.nih.gov/36251574
Autor:
Vidit Sharma, Kevin M. Wymer, Daniel D. Joyce, James Moriarty, Bijan J. Borah, R. Houston Thompson, Brian A. Costello, Bradley C. Leibovich, Stephen A. Boorjian
Publikováno v:
Journal of Urology. 207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::083eda26ee166bcb177a9529416e8275
https://doi.org/10.1097/ju.0000000000002644.05
https://doi.org/10.1097/ju.0000000000002644.05
Autor:
Daniel D. Joyce, Kevin M. Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Daniel M. Geynisman, Elizabeth R. Plimack, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian
Publikováno v:
Journal of Urology. 207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de2587a57d22587311fd8d0451e87ea0
https://doi.org/10.1097/ju.0000000000002599.13
https://doi.org/10.1097/ju.0000000000002599.13
Autor:
Darlene, Vargas Maldonado, Kevin M, Wymer, John B, Gebhart, Annetta M, Madsen, John A, Occhino, Emanuel C, Trabuco, Brian J, Linder
Publikováno v:
Female pelvic medicinereconstructive surgery. 28(3)
The aim of this study was to perform a cost-effectiveness analysis comparing the management for ongoing voiding dysfunction after midurethral sling placement, including early sling loosening and delayed sling lysis.A Markov model was created to compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4c565fcd08174e049c46251a409ba53
https://pubmed.ncbi.nlm.nih.gov/35272342
https://pubmed.ncbi.nlm.nih.gov/35272342
Autor:
Kevin M. Wymer, Aaron M. Potretzke
Publikováno v:
Urology. 159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0a7541e907732112ef4a9cc638e869a
https://pubmed.ncbi.nlm.nih.gov/35027176
https://pubmed.ncbi.nlm.nih.gov/35027176
Autor:
Vidit Sharma, Kevin M Wymer, Daniel D. Joyce, James P. Moriarty, Bijan J Borah, R. Houston Thompson, Brian Addis Costello, Bradley C. Leibovich, Stephen A. Boorjian
Publikováno v:
Journal of Clinical Oncology. 40:321-321
321 Background: KEYNOTE-564 demonstrated that adjuvant pembrolizumab after nephrectomy for high-risk clear cell renal cell carcinoma (RCC) decreased the risk of disease progression and – albeit with immature follow-up (2 years) – found a signal o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8840bd3bbb1f3dc365826277d649a7a
https://doi.org/10.1200/jco.2022.40.6_suppl.321
https://doi.org/10.1200/jco.2022.40.6_suppl.321